ZSCAN1
gene geneOn this page
Also known as FLJ33779ZNF915
Summary
ZSCAN1 (zinc finger and SCAN domain containing 1, HGNC:23712) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger and SCAN domain-containing protein 1 (Q8NBB4). May be involved in transcriptional regulation.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in chromatin.
Source: NCBI Gene 284312 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 83 total
- MANE Select transcript:
NM_182572
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23712 |
| Approved symbol | ZSCAN1 |
| Name | zinc finger and SCAN domain containing 1 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ33779, ZNF915 |
| Ensembl gene | ENSG00000152467 |
| Ensembl biotype | protein_coding |
| OMIM | 620026 |
| Entrez | 284312 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000282326, ENST00000391700, ENST00000601162
RefSeq mRNA: 1 — MANE Select: NM_182572
NM_182572
CCDS: CCDS12969
Canonical transcript exons
ENST00000282326 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001183770 | 58037728 | 58038206 |
| ENSE00001251640 | 58053429 | 58054631 |
| ENSE00001251651 | 58052490 | 58052628 |
| ENSE00001251668 | 58040450 | 58040544 |
| ENSE00001251687 | 58035970 | 58036011 |
| ENSE00001251701 | 58034025 | 58034161 |
Expression profiles
Bgee: expression breadth ubiquitous, 138 present calls, max score 85.39.
FANTOM5 (CAGE): breadth broad, TPM avg 1.8456 / max 61.2894, expressed in 434 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177810 | 1.2604 | 376 |
| 177809 | 0.5853 | 249 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adenohypophysis | UBERON:0002196 | 85.39 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.76 | gold quality |
| pituitary gland | UBERON:0000007 | 81.74 | gold quality |
| right uterine tube | UBERON:0001302 | 81.50 | gold quality |
| hypothalamus | UBERON:0001898 | 77.63 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.01 | silver quality |
| left lobe of thyroid gland | UBERON:0001120 | 75.64 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 75.56 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 75.50 | gold quality |
| right frontal lobe | UBERON:0002810 | 74.89 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.45 | gold quality |
| left testis | UBERON:0004533 | 74.27 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 73.88 | gold quality |
| right testis | UBERON:0004534 | 73.86 | gold quality |
| thyroid gland | UBERON:0002046 | 73.32 | gold quality |
| amygdala | UBERON:0001876 | 73.04 | gold quality |
| nucleus accumbens | UBERON:0001882 | 72.46 | gold quality |
| caudate nucleus | UBERON:0001873 | 71.49 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 71.36 | gold quality |
| putamen | UBERON:0001874 | 71.25 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 71.14 | gold quality |
| testis | UBERON:0000473 | 70.82 | gold quality |
| ventricular zone | UBERON:0003053 | 70.65 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 70.63 | gold quality |
| cerebellar cortex | UBERON:0002129 | 70.58 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 70.32 | gold quality |
| neocortex | UBERON:0001950 | 69.24 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 68.96 | gold quality |
| cortical plate | UBERON:0005343 | 68.60 | gold quality |
| cerebellum | UBERON:0002037 | 68.50 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.01 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting ZSCAN1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-548O-3P | 99.74 | 69.30 | 2228 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-6853-3P | 99.36 | 70.79 | 1558 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-6815-3P | 99.13 | 68.98 | 1530 |
| HSA-MIR-224-3P | 98.91 | 68.42 | 1815 |
| HSA-MIR-522-3P | 98.91 | 68.56 | 1817 |
| HSA-MIR-10A-5P | 98.89 | 69.85 | 712 |
| HSA-MIR-10B-5P | 98.89 | 69.86 | 711 |
| HSA-MIR-6846-5P | 98.81 | 65.86 | 1121 |
| HSA-MIR-6848-5P | 98.81 | 65.49 | 1126 |
| HSA-MIR-3136-5P | 98.53 | 67.68 | 793 |
| HSA-MIR-4439 | 98.53 | 67.53 | 793 |
| HSA-MIR-518C-5P | 98.53 | 69.20 | 1640 |
| HSA-MIR-4669 | 97.94 | 62.71 | 224 |
| HSA-MIR-3657 | 96.33 | 66.29 | 608 |
| HSA-MIR-4513 | 95.04 | 67.06 | 727 |
| HSA-MIR-6855-3P | 95.04 | 66.57 | 725 |
| HSA-MIR-5588-3P | 94.96 | 65.59 | 500 |
| HSA-MIR-764 | 94.16 | 64.85 | 656 |
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | plagx | ENSDARG00000036855 |
| danio_rerio | ovol1a | ENSDARG00000076472 |
| danio_rerio | plagl2 | ENSDARG00000076657 |
| danio_rerio | ovol1b | ENSDARG00000078256 |
| drosophila_melanogaster | hb | FBGN0001180 |
| drosophila_melanogaster | CG12391 | FBGN0033581 |
| caenorhabditis_elegans | WBGENE00001824 | |
| caenorhabditis_elegans | WBGENE00003033 | |
| caenorhabditis_elegans | WBGENE00012385 |
Paralogs (29): ZNF446 (ENSG00000083838), REST (ENSG00000084093), ZNF174 (ENSG00000103343), OVOL3 (ENSG00000105261), PLAGL1 (ENSG00000118495), ZSCAN18 (ENSG00000121413), ZNF576 (ENSG00000124444), OVOL2 (ENSG00000125850), PLAGL2 (ENSG00000126003), ZSCAN5A (ENSG00000131848), ZSCAN29 (ENSG00000140265), ZSCAN32 (ENSG00000140987), ZNF18 (ENSG00000154957), ZKSCAN2 (ENSG00000155592), ZNF496 (ENSG00000162714), ZNF202 (ENSG00000166261), ZNF641 (ENSG00000167528), ZNF444 (ENSG00000167685), SCAND1 (ENSG00000171222), ZNF274 (ENSG00000171606), ZNF131 (ENSG00000172262), OVOL1 (ENSG00000172818), ZNF518A (ENSG00000177853), ZNF518B (ENSG00000178163), PLAG1 (ENSG00000181690), ZSCAN5B (ENSG00000197213), ZNF770 (ENSG00000198146), PEG3 (ENSG00000198300), ZSCAN5C (ENSG00000204532)
Protein
Protein identifiers
Zinc finger and SCAN domain-containing protein 1 — Q8NBB4 (reviewed: Q8NBB4)
All UniProt accessions (2): Q8NBB4, A0A0C4DGR0
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NBB4-1 | 1 | yes |
| Q8NBB4-2 | 2 |
RefSeq proteins (1): NP_872378* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003309 | SCAN_dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR038269 | SCAN_sf | Homologous_superfamily |
| IPR050916 | SCAN-C2H2_zinc_finger | Family |
Pfam: PF00096, PF02023
UniProt features (15 total): region of interest 5, zinc finger region 3, splice variant 2, sequence conflict 2, chain 1, domain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NBB4-F1 | 60.15 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 22 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_UP, FIGUEROA_AML_METHYLATION_CLUSTER_1_UP, FIGUEROA_AML_METHYLATION_CLUSTER_3_UP, FIGUEROA_AML_METHYLATION_CLUSTER_6_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR153_5P, MIR6853_3P, MIR3136_5P, MIR4439, MANNO_MIDBRAIN_NEUROTYPES_HRGL3, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
908 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZSCAN1 | PLVAP | Q9BX97 | 712 |
| ZSCAN1 | MAZ | P56270 | 658 |
| ZSCAN1 | TGFB1 | P01137 | 574 |
| ZSCAN1 | USF1 | P22415 | 537 |
| ZSCAN1 | NKX2-5 | P52952 | 502 |
| ZSCAN1 | GATA1 | P15976 | 486 |
| ZSCAN1 | POU2F1 | P14859 | 478 |
| ZSCAN1 | ZNF174 | Q15697 | 463 |
| ZSCAN1 | ZNF202 | O95125 | 459 |
| ZSCAN1 | INSM1 | Q01101 | 453 |
| ZSCAN1 | POU3F2 | P20265 | 451 |
| ZSCAN1 | RUBCNL | Q9H714 | 445 |
| ZSCAN1 | KLF6 | Q99612 | 443 |
| ZSCAN1 | SMAD3 | P84022 | 442 |
| ZSCAN1 | EIF2AK1 | Q9BQI3 | 435 |
IntAct
47 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PPL | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN1 | GOPC | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN1 | PPL | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOPC | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN1 | SH2D2A | psi-mi:“MI:0915”(physical association) | 0.490 |
| SH2D2A | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.490 |
| CDK6 | ZSCAN1 | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
| ZNF263 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SSX3 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TRIM31 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ERCC3 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SNW1 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZKSCAN5 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CNOT6L | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF396 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZSCAN1 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| GTF2E1 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| GTF2H1 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NPAS2 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MED31 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PLRG1 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| POLR2B | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| POLR2D | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| POLR2E | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPARG | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF407 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TBX20 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RFC1 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (74): ZSCAN1 (Two-hybrid), ZSCAN1 (Two-hybrid), ZNF24 (Affinity Capture-MS), ZSCAN25 (Affinity Capture-MS), GOLGA3 (Affinity Capture-MS), ZNF174 (Affinity Capture-MS), ZNF496 (Affinity Capture-MS), ZSCAN18 (Affinity Capture-MS), PM20D2 (Affinity Capture-MS), MZF1 (Affinity Capture-MS), PGBD1 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZSCAN1 (Two-hybrid), ZSCAN18 (Affinity Capture-MS), ZNF174 (Affinity Capture-MS)
ESM2 similar proteins: A1YGK1, A2T7E6, A4D1S0, A9YTQ3, B1WBS3, I7HJS4, O43593, O43918, O60304, O75593, O95201, P0C6A0, P0C7X2, P97609, Q2MHN3, Q3B7M4, Q3SY56, Q3U133, Q58DK7, Q5JPB2, Q5SXI5, Q5T619, Q61645, Q6KAU7, Q6NUN9, Q6ZMS7, Q76NI1, Q7Z6P3, Q8BZ34, Q8BZW2, Q8CGW9, Q8IWN7, Q8IXT2, Q8IZ20, Q8NBB4, Q8NDX1, Q8NHY3, Q91X45, Q96PX9, Q99558
Diamond homologs: A1YEP8, A1YEQ3, A1YEV9, A1YFC1, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A1YGK6, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F2, A2T7F4, A2T7L7, A2T812, A6QNZ0, A6QPT6, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17040, P28698, P49910, P51815
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 40 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 5 | 70.3× | 1e-07 |
| RNA Pol II CTD phosphorylation and interaction with CE | 5 | 70.3× | 1e-07 |
| mRNA Capping | 5 | 65.6× | 2e-07 |
| Formation of the Early Elongation Complex | 5 | 57.9× | 2e-07 |
| Formation of the HIV-1 Early Elongation Complex | 5 | 57.9× | 2e-07 |
| HIV Transcription Initiation | 7 | 56.3× | 9e-10 |
| RNA Polymerase II HIV Promoter Escape | 7 | 56.3× | 9e-10 |
| RNA Polymerase II Promoter Escape | 7 | 56.3× | 9e-10 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| transcription initiation at RNA polymerase II promoter | 6 | 57.6× | 2e-07 |
| transcription by RNA polymerase II | 8 | 14.5× | 9e-06 |
| DNA repair | 6 | 9.8× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
83 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 75 |
| Likely benign | 5 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1264 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:58038203:G:GT | donor_gain | 1.0000 |
| 19:58038204:A:T | donor_gain | 1.0000 |
| 19:58040445:CACA:C | acceptor_loss | 1.0000 |
| 19:58040447:C:G | acceptor_gain | 1.0000 |
| 19:58040447:CA:C | acceptor_loss | 1.0000 |
| 19:58040448:A:AC | acceptor_loss | 1.0000 |
| 19:58040448:A:AG | acceptor_gain | 1.0000 |
| 19:58040449:G:GC | acceptor_gain | 1.0000 |
| 19:58040449:GT:G | acceptor_gain | 1.0000 |
| 19:58040449:GTT:G | acceptor_gain | 1.0000 |
| 19:58040449:GTTC:G | acceptor_gain | 1.0000 |
| 19:58040449:GTTCT:G | acceptor_gain | 1.0000 |
| 19:58040540:CGCAG:C | donor_loss | 1.0000 |
| 19:58040542:CAGG:C | donor_loss | 1.0000 |
| 19:58040543:AGGTG:A | donor_loss | 1.0000 |
| 19:58040544:GGTGA:G | donor_loss | 1.0000 |
| 19:58040546:T:A | donor_loss | 1.0000 |
| 19:58052489:GGC:G | acceptor_gain | 1.0000 |
| 19:58053427:AG:A | acceptor_gain | 1.0000 |
| 19:58053428:GG:G | acceptor_gain | 1.0000 |
| 19:58034157:GCGCG:G | donor_gain | 0.9900 |
| 19:58034158:CGCGG:C | donor_loss | 0.9900 |
| 19:58034159:GCG:G | donor_gain | 0.9900 |
| 19:58034162:G:GG | donor_gain | 0.9900 |
| 19:58034162:GTGA:G | donor_loss | 0.9900 |
| 19:58034163:T:A | donor_loss | 0.9900 |
| 19:58034164:GA:G | donor_loss | 0.9900 |
| 19:58035959:T:G | acceptor_gain | 0.9900 |
| 19:58036061:G:GT | donor_gain | 0.9900 |
| 19:58037099:G:GT | donor_gain | 0.9900 |
AlphaMissense
2653 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:58038183:T:C | L116P | 0.999 |
| 19:58053725:T:C | F301L | 0.999 |
| 19:58053727:C:A | F301L | 0.999 |
| 19:58053727:C:G | F301L | 0.999 |
| 19:58053809:T:C | F329L | 0.999 |
| 19:58053810:T:C | F329S | 0.999 |
| 19:58053811:C:A | F329L | 0.999 |
| 19:58053811:C:G | F329L | 0.999 |
| 19:58053989:T:C | F389L | 0.999 |
| 19:58053991:C:A | F389L | 0.999 |
| 19:58053991:C:G | F389L | 0.999 |
| 19:58038084:T:C | L83P | 0.998 |
| 19:58038093:T:C | F86S | 0.998 |
| 19:58038171:T:C | L112P | 0.998 |
| 19:58053726:T:C | F301S | 0.998 |
| 19:58053788:T:C | C322R | 0.998 |
| 19:58053968:T:C | C382R | 0.998 |
| 19:58053990:T:C | F389S | 0.998 |
| 19:58054008:T:C | L395P | 0.998 |
| 19:58054016:C:G | H398D | 0.998 |
| 19:58054018:C:A | H398Q | 0.998 |
| 19:58054018:C:G | H398Q | 0.998 |
| 19:58038012:T:C | L59P | 0.997 |
| 19:58038075:T:C | L80P | 0.997 |
| 19:58038092:T:C | F86L | 0.997 |
| 19:58038094:C:A | F86L | 0.997 |
| 19:58038094:C:G | F86L | 0.997 |
| 19:58038105:T:C | L90P | 0.997 |
| 19:58053744:T:C | F307S | 0.997 |
| 19:58053752:C:G | H310D | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000214354 (19:58040308 T>A), RS1000263351 (19:58034352 C>A), RS1000336971 (19:58045009 C>G), RS1000375428 (19:58035958 A>C,G), RS1000604168 (19:58035670 G>A), RS1000654806 (19:58035951 T>C), RS1000662220 (19:58045420 G>A), RS1000687422 (19:58045155 C>T), RS1000699435 (19:58052331 C>T), RS1000773036 (19:58052485 T>C), RS1000847773 (19:58039387 C>T), RS1001194724 (19:58054979 G>A), RS1001283556 (19:58049306 T>A), RS1001288476 (19:58055012 C>T), RS1001447916 (19:58049912 G>T)
Disease associations
OMIM: gene MIM:620026 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation, increases methylation | 2 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| Methapyrilene | decreases methylation | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Triclosan | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.